GRANTRYL

This brand name is authorized in South Africa

Active ingredients

The drug GRANTRYL contains one active pharmaceutical ingredient (API):

1 Granisetron
UNII 318F6L70J8 - GRANISETRON HYDROCHLORIDE

Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy.

Read about Granisetron

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
GRANTRYL Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic
GRANTRYL Film-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A04AA02 Granisetron A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists
Discover more medicines within A04AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ZA Health Products Regulatory Authority Identifier(s): 43/5.7.2/0527, 43/5.7.2/0528, 44/5.7.2/0892, 44/5.7.2/0893

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.